OpGen Inc. (CFOR)

Profile

https://www.capforce.inc

OpGen Inc. is a precision medicine company that has repositioned its business to focus on digital investment banking and financial technology through its subsidiary CapForce International Holdings Ltd. It offers listing sponsorship and capital market services to mid-sized growth-stage private companies worldwide targeting public market listings with market capitalizations between USD1 billion and USD10 billion. CapForce is developing a next-generation global digital investment banking platform to support cross-border securities trading, AI-driven robo-advisory for investment banking and asset management, and FinTech-enabled cap table management solutions. These services aim to facilitate efficient access to public markets and advanced financial tools for growth-oriented firms. Previously centered on molecular microbiology solutions for life-threatening infectious diseases, including products like Unyvero systems and Acuitas AMR Gene Panel tests, as well as laboratory and collaboration services, OpGen Inc. now emphasizes its current fintech and capital markets segments. Incorporated in 2001 and headquartered in Rockville, Maryland, OpGen Inc. operates in the evolving intersection of healthcare diagnostics and financial services.